RIGL
Rigel Pharmaceuticals Inc
Price:  
20.82 
USD
Volume:  
168,591.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL Relative Valuation

-72.7%
Upside

As of 2025-02-13, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 5.68 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.82 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is -72.7%.

The range of the Relative Valuation is 3.39 - 8.55 USD.

Range Selected
Trailing P/E multiples 16.5x - 38.8x 27.6x
Forward P/E multiples 15.4x - 32.4x 23.9x
Fair Price 3.39 - 8.55 5.68
Upside -83.7% - -59.0% -72.7%
20.82 USD
Stock Price
5.68 USD
Fair Price

RIGL Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 99.61
2025-02-06 110.73
2025-02-05 103.70
2025-02-04 94.71
2025-02-03 96.07
2025-01-31 98.29
2025-01-30 102.61
2025-01-29 102.11
2025-01-28 100.61
2025-01-27 98.61
2025-01-24 100.65
2025-01-23 100.52
2025-01-22 99.02
2025-01-21 99.02
2025-01-17 91.39
2025-01-16 78.77
2025-01-15 81.77
2025-01-14 75.77
2025-01-13 77.68
2025-01-10 73.78
2025-01-08 73.78
2025-01-07 77.59
2025-01-06 75.37
2025-01-03 78.91
2025-01-02 78.63
2024-12-31 76.36
2024-12-30 74.77
2024-12-27 74.91
2024-12-26 78.36
2024-12-24 74.64
2024-12-23 77.86
2024-12-20 77.59
2024-12-19 78.13
2024-12-18 77.50
2024-12-17 83.76
2024-12-16 86.90
2024-12-13 85.85
2024-12-12 86.31
2024-12-11 88.67
2024-12-10 93.34
2024-12-09 105.15
2024-12-06 115.54
2024-12-05 118.18
2024-12-04 120.27
2024-12-03 122.81
2024-12-02 122.81
2024-11-29 125.35
2024-11-27 126.58
2024-11-26 121.22
2024-11-25 118.45